Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience
Objective. To evaluate, in three Spanish tertiary referral centres, the short-term safety and efficacy of golimumab (GLM) for treatment of immune-mediated uveitis resistant to previous immunosuppressive therapy. Methods. Nonrandomized retrospective interventional case series. Thirteen patients with...
Saved in:
| Main Authors: | Miguel Cordero-Coma, Vanesa Calvo-Río, Alfredo Adán, Ricardo Blanco, Carolina Álvarez-Castro, Marina Mesquida, Sara Calleja, Miguel A. González-Gay, José G. Ruíz de Morales |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2014/717598 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01) -
Proinflammatory Cytokines and C-Reactive Protein in Uveitis Associated with Behçet’s Disease
by: Marina Mesquida, et al.
Published: (2014-01-01) -
Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis.
by: Jessica Matas, et al.
Published: (2019-01-01) -
GOLIMUMAB SAFETY ACCORDING TO CLINICAL FINDINGS
by: G. V. Lukina, et al.
Published: (2015-04-01) -
The abilities of golimumab in the therapy of ankylosing spondylitis
by: Sh. F. Erdes
Published: (2014-09-01)